APTAMERS

APTAMERS are synthetic antibodies that has the potential to replace current animal-harvested antibodies for molecular diagnostics applications in human healthcare, animal breeding, agriculture and food safety

BIOGENES has taken the science of aptamers to another level by using bio-computational technique to design and optimise the binding between aptamers and target molecules in a 3D virtual environment – at least 20X faster and cheaper than conventional lab-based methods.

APTAMERS AS SYNTHETIC ANTIBODIES

vs

ANIMAL HARVESTED ANTIBODIES

DNA-BASED, MORE STABLE

PROTEIN-BASED, LESS STABLE

LAB-SYNTHESIZED TO PRECISE SPECS

VARIATIONS IN PRODUCTION BATCH

NO ANIMALS ARE INVOLVED

ETHICAL ISSUES ON ANIMAL USE*

LOW COST TO SYNTHESIZE DNA OLIGONUCLEOTIDES

HIGH COST IN PRODUCTION & COMPLIANCE

MAN-MADE HENCE PATENTABLE

COMPLICATED PATENTING CRITERIA